对于泌尿系统恶性肿瘤患者而言，癌症幸存者的存活特别重要，这些患者占癌症幸存者的>25%。美国癌症协会有一个有关前列腺癌幸存护理的指南，而美国泌尿科协会则在泌尿系统癌症幸存中发表了核心课程。然而，在幸存策略方面，缺乏高质量的证据来支持指南推荐。未来需要着重于产生高质量的幸存研究，以及增加适当的资源来改善幸存护理的实施。患者简介：针对前列腺、膀胱、阴茎或肾癌患者的幸存护理指南很少。需要更多的经费进行癌症幸存者护理研究。版权所有©2023年欧洲泌尿科协会。由Elsevier B.V.出版。保留所有权利。

Cancer survivorship is particularly significant for patients with urologic malignancies, who account for >25% of cancer survivors. The American Cancer Society has a guideline on survivorship care in prostate cancer and the American Urological Association has published a core curriculum on cancer survivorship in urologic cancers. However, there is a lack of high-quality evidence on survivorship strategies to inform guideline recommendations. Future efforts need to focus on producing high-quality survivorship research and on increasing appropriate resources to improve the implementation of survivorship care. PATIENT SUMMARY: There are few guidelines on survivorship care for patients with prostate, bladder, penile, or kidney cancer. More funding is needed for research into care for cancer survivors.Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.